Safety and tolerability of long-term administration of Dilaudid CR [controlled release] (hydromorphone HCI)
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2009
At a glance
- Drugs Hydromorphone (Primary)
- Indications Cancer pain; Pain
- Focus Therapeutic Use
- Sponsors ALZA Corporation
- 14 Jul 2009 Actual patient number (388) added as reported by ClinicalTrials.gov.
- 14 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jan 2007 New trial record.